Friday, November 22, 2024
11/22/2024
PROJECT SUMMARY: This study tests a novel hypothesis that 1,25(OH)2D, i.e. the active vitamin D metabolite, augments regenerative capacity of the Lgr5+ intestinal stem cells (ISCs). To test this hypothesis, we are proposing two specific aims. Specific Aim 1 will determine whether 1,25(OH)2D promotes regenerative capacity of the Lgr5+ ISCs by in vivo tracing of the Lgr5+ ISCs and their progenies in the entire process of intestinal epithelium regeneration. We will use our previously developed strategy to deliver a locally high 1,25(OH)2D concentration to the intestines. Regenerative capacity will be determined by abundance, migration, proliferation, survivability, and differentiation of the Lgr5+ ISCs. In this specific aim, one study will be performed in normal healthy animals (Objective 1A). To determine clinical significance, the other study will be performed in animals induced for experimental colitis (Objective 1B). In both objectives, we will use immunohistochemistry (IHC) to investigate the entire regenerative process of the Lgr5+ ISCs. To do this, we will trace the Lgr5+ ISCs using F1 offspring of the cre-inducible Lgr5-EGFP-IRES-creERT2 (Lgr5-GFP) and the cre-reporter B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J (Ai9 or Ai) mice. In the Lgr5-GFP mice, GFP expression is under the control of Lgr5 promoter and enhancer and Cre can be induced by tamoxifen injection. Additionally, the Ai mice express tdTomato when Cre is present independent of Lgr5 expression. Consequently, the F1 offspring (Lgr5-GFP-Ai mice), upon tamoxifen administration to activate the Cre, will express both GFP and tdTomato in crypt Lgr5+ ISCs but will only express tdTomato in the progenies of Lgr5+ ISCs outside the crypts. Since normal intestinal epithelia are replaced every 4-5 days, at days 1, 3, and 5 immediately following the 1,25(OH)2D delivery, we will study abundance of the Lgr5+ ISCs by staining for GFP, migration for tdTomato, proliferation for Brdu, survivability for bcl-2 and caspase 3, and differentiation for markers specific for each type of epithelial cells. Specific Aim 2 will determine whether the effects of 1,25(OH)2D treatment on regenerative capacity of the Lgr5+ ISCs depend on vitamin D receptor (VDR) using in vitro cultured multipotent Lgr5+ ISC lines. Since 1,25(OH)2D can function through both VDR-dependent and independent mechanisms, this study will investigate whether 1,25(OH)2D acts on the Lgr5+ ISCs directly through VDR signaling or indirectly via a VDR-independent mechanism. We will purify the Lgr5+ ISCs from Lgr5-GFP mice and establish multipotent Lgr5+ ISC lines in a multipotent medium. Using the multipotent Lgr5+ ISC lines, we will reach two objectives. Objective 2A will investigate the effects of 1,25(OH)2D treatment on proliferation (Ki-67) and survivability (bcl-2 and caspase 3) of the multipotent Lgr5+ ISCs with or without VDR knockdown. Objective 2B will examine the effects of 1,25(OH)2D treatment on differentiation of the Lgr5+ ISCs in a differentiation medium with or without VDR knockdown. The ultimate goal is to develop a 1,25(OH)2D- based strategy to enhance epithelium repair for the treatment of inflammatory bowel disease.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
